Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Amicus Brief
Oct 22, 2021
| Rachel Schwartz
GLAXOSMITHKLINE LLC and SMITHKLINE BEECHAM (CORK) LIMITED v. TEVA PHARMACEUTICALS USA, INC.
Blog
Oct 18, 2021
| Dan Leonard
AAM All Access Podcast: Lupin’s Vinita Gupta
Blog
Oct 18, 2021
| Rachel Schwartz
Five Breast Cancer Facts
Blog
Oct 16, 2021
| Dan Leonard
AAM All Access Podcast: Apotex’s Jeff Watson
Fact Sheet
Oct 12, 2021
| Erica Klinger
The Generic Drug User Fee Amendments (GDUFA III)
Report
Oct 12, 2021
| Erica Klinger
Report: 2021 U.S. Generic and Biosimilar Medicines Savings Report
Blog
Oct 8, 2021
| Dan Leonard
AAM All Access Podcast: Golden State Medical Supply’s Anthony Principi
Press Release
Oct 6, 2021
| Rachel Schwartz
Christine Simmon Named Executive Vice President, Policy and Strategic Alliances for the Association for Accessible Medicines
Blog
Oct 1, 2021
| Dan Leonard
Celebrating One Year as AAM CEO
Blog
Sep 30, 2021
| Dan Leonard
A Commitment to Membership Enhances AAM’s Mission
Blog
Sep 21, 2021
| Bob Billings
Thank you, Kanu Patel
Press Release
Sep 21, 2021
| Rachel Schwartz
Study Finds U.S. Generic and Biosimilar Savings Totaled A Record $338 Billion in 2020
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action